Australia doubles Pfizer vaccine order as clotting worries upend rollout

Published
0

Australia has doubled its order of the Pfizer Inc Covid-19 vaccine, Prime Minister Scott Morrison said, as the country raced to overhaul its inoculation plan over concerns about the risks of blood clots with the AstraZeneca Plc vaccine.

Until late Thursday, Australia based its vaccination programme largely on AstraZeneca shot, with an order for 50 million doses — enough for the required two shots for its entire 25 million population — to be made domestically by biopharma CSL Ltd.

But Australia has now joined a host of countries in restricting use of the vaccine due to clotting concerns. Local health authorities have changed their recommendation to say the country's nearly 12 million people aged under 50 should take the Pfizer product instead, according to Reuters.

As a result Australia has doubled an earlier Pfizer order to 40 million shots, enough for four-fifths of the population, which would be delivered by the end of the year, Morrison said.

Opinion

Editorial

Yemen offensive
Updated 04 Oct, 2026

Yemen offensive

The best option, therefore, is for Muslim and Arab states to help restore the Saudi-Houthi ceasefire.
Growth transition
04 Oct, 2026

Growth transition

PRIME Minister Shehbaz Sharif’s recent call to move from stabilisation to growth, job creation and export ...
Protection at risk
04 Oct, 2026

Protection at risk

THE recent warning from UNHCR should alarm donor governments. Nearly 8.3m refugees and other forcibly displaced...
Talks, at last
Updated 03 Oct, 2026

Talks, at last

The government’s constant threats to suspend KP’s elected dispensation over a political protest have escalated hostilities considerably. In that context, both sides did well to start talking.
IWT’s future
Updated 03 Oct, 2026

IWT’s future

TOGETHER with the Kashmir dispute, India’s unilateral suspension of the Indus Waters Treaty has become the biggest...
Pained minds
03 Oct, 2026

Pained minds

IN Pakistan, mental healthcare is wedged between two extremes — a luxury or a stigma. Estimates cited by the...